About
Agios Pharm (NASDAQ:AGIO) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 6 2026
Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET
Mar 31 2026
Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA
Mar 2 2026
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in the United Arab Emirates
Feb 12 2026
Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Jan 26 2026
Agios to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast on February 12 at 8:00 a.m. ET
Financials
Revenue
$54.03 M
Market Cap
$2.06 B
EPS
-7.12
Translate